A significant interaction effect of intrauterine growth restriction and treatment on IL-1β (P = 0.002) and IL-6 (P = 0.02) production was confirmed by two-way ANOVA, indicating that these factors acted dependently. The gene discussed is IL1B; the disease is fetal growth restriction.